###begin article-title 0
Expression of Cre recombinase in dopaminoceptive neurons
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 530 535 530 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a</italic>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
###xml 454 459 <span type="species:ncbi:4932">yeast</span>
Dopamine-activated signaling regulates locomotor and emotional responses and alterations in dopamine-signaling are responsible of several psychomotor disorders. In order to identify specific functions of these pathways, the Cre/loxP system has been used. Here, we describe the generation and the characterization of a transgenic mouse line expressing the Cre recombinase in dopaminoceptive neurons. To this purpose, we used as expression vector a 140 kb yeast artificial chromosome (YAC) containing the dopamine D1 receptor gene (Drd1a).
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Creb1</italic>
###xml 304 308 304 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP</sup>
###xml 310 316 310 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CaMKIV</italic>
###xml 316 321 316 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 325 327 325 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GR</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP</sup>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R </italic>
In the chosen line, D1Cre, the spatio-temporal pattern of Cre expression closely recapitulated that of the endogenous Drd1a gene, as assessed by immunohistological approaches in embryonic and adult stages. Efficiency of recombination was confirmed by crossing D1Cre with three different loxP lines (Creb1loxP, CaMKIVloxP and GRloxP) and with the R26R reporter. In the three loxP lines studied, recombination was restricted to the area of Cre expression.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
In view of the patterns of recombination restricted to the major dopaminoceptive regions as seen in the context of the CREB, CaMKIV and GR mutations, the D1Cre line will be a useful tool to dissect the contributions of specific genes to biological processes involving dopamine signaling.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a</italic>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd2</italic>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd3</italic>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd4 </italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd5 </italic>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 61 64 <span type="species:ncbi:10116">rat</span>
###xml 341 346 <span type="species:ncbi:9606">human</span>
Although dopaminergic neurons are few (e.g. 10-20,000 in the rat brain), they regulate a number of physiological, behavioral and cognitive functions, including regulation of locomotor activity, incentive behaviors, short-term and stimulus-dependent memory systems [1-3]. Dysfunction of the dopaminergic system and its targets underlie major human disorders such as Parkinson's disease, Huntington's disease, schizophrenia and addiction to drugs of abuse [4-6]. Five dopamine receptors, termed D1, D2,D3, D4 and D5, encoded by five different genes (Drd1a, Drd2, Drd3, Drd4 and Drd5 respectively) have been identified [7,8]. The elucidation of the signaling properties of dopaminoceptive neurons is of central importance for the development of therapeutic strategies to treat dysfunctions of the dopaminergic system.
###end p 9
###begin p 10
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
In the past years, use of the Cre/loxP system has enabled generation of cell-specific mutations In the central nervous system, efforts have generally been devoted to the generation of region-specific mutations using promoters to drive the expression of Cre recombinase in specific brain areas [9-11]. In order to target the dopaminoceptive neurons, we have generated a transgenic line that expresses Cre recombinase in dopaminoceptive neurons under the control of the dopamine D1 receptor gene (D1Cre), by using the genomic locus of a dopamine D1 receptor gene cloned in a YAC vector.
###end p 10
###begin p 11
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 425 431 425 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
Here we examine the cellular expression of Cre recombinase in D1Cre transgenic mice by immunohistochemistry in combination with in situ hybridization, to compare it with the expression of D1 receptor mRNA and other dopaminoceptive molecular markers. The activity of the Cre was confirmed by loss of CREB, CaMKIV and GR proteins in the respective conditional mutants and by induction of beta-galactosidase activity in the R26RD1Cre reporter mice.
###end p 11
###begin title 12
Results
###end title 12
###begin p 13
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a</italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 347 353 347 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 558 564 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 687 693 687 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 751 757 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 9 14 <span type="species:ncbi:4932">yeast</span>
###xml 127 132 <span type="species:ncbi:10090">mouse</span>
###xml 389 394 <span type="species:ncbi:4932">yeast</span>
A 140 kb yeast artificial chromosome (YAC) containing the entire dopamine D1 receptor gene (Drd1a) was isolated by screening a mouse genomic YAC library [12]. The YAC encompasses the entire Drd1a gene including 40 kb of upstream and 100 kb of downstream sequences. The coding sequence for the nuclear localized nlsCre [13] was introduced into the Drd1a gene by homologous recombination in yeast. To minimize the chances of altering possible regulatory elements, we avoided the use of a heterologous polyadenylation sequence and minimized the deletion of the Drd1a coding sequence. Specifically, the homology regions were chosen so that the ATG of the nlsCre would replace the ATG of the Drd1a gene and the STOP codon of the nlsCre would interrupt the Drd1a open reading frame after its last possible internal ATG.
###end p 13
###begin p 14
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 522 523 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1063 1064 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1140 1141 1140 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1388 1393 1388 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a, b</xref>
The modified YAC was used to generate 5 independent transgenic lines (D1Cre lines A, R, S, T and U). Two lines (T and U) carried incomplete copies of the transgene as assessed by screening for the presence of the extremities of the YAC arms (data not shown). Examination of Cre expression by immunohistochemistry in the three remaining lines (A, R and S) revealed a virtually identical pattern of expression (Fig. 1). Moreover, the level of expression was in direct correlation with the copy number of the transgene (Fig. 1). Detailed analysis of the Cre expression pattern was conducted with line A which carries three copies of the YAC transgene. Expression was prominent in the major projections areas of the dopaminergic system, including striatum, nucleus accumbens, olfactory tubercles and prefrontal cortex (Fig. 2). Clear but lower expression was seen in layer VI of the cortex. In hippocampus, CA2 and scattered cells in the dentate gyrus expressed Cre (Fig. 2). Several thalamic nuclei and the ventromedian hypothalamic nucleus also expressed Cre (Fig. 2). In retina, robust staining was observed in the inner nuclear layer (Fig. 2). In order to verify that Cre is expressed in neurons expressing the D1R mRNA, we have performed in situ hybridization with a specific D1R riboprobe in combination with immunohistochemical detection of Cre expression in striatum and cortex (Fig. 3a, b).
###end p 14
###begin p 15
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Position-independent and copy-number dependent expression of the D1Cre YAC transgene</bold>
###xml 87 88 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 143 144 143 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 211 214 211 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c-e</bold>
###xml 306 307 306 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 807 810 807 810 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b-e</bold>
Position-independent and copy-number dependent expression of the D1Cre YAC transgene. (a) Schematic representation of the modified D1Cre YAC. (b) Schematic view of the known distribution of Drd1a mRNA [29, 38].(c-e) Expression pattern of Cre as revealed by immunohistochemistry in D1Cre transgenic lines. (c) Line R, (d) line A and (e) line S. The accompanying Southern blots show the copy number dependent expression of Cre. The upper band is the endogenous Drd1a gene and the lower band is the D1Cre YAC transgene. Abbreviations: CL: centrolateral thalamic nucleus; CM: central medial thalamic nucleus; CPu: caudate putamen; DG: dentate gyrus; LD: laterodorsal thalamic nucleus; VL: ventrolateral thalamic nucleus;VM: ventromedial thalamic nucleus; VMH: ventromedial hypothalamic nucleus. Magnification: (b-e) 5x.
###end p 15
###begin p 16
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detailed pattern of Cre expression</bold>
###xml 37 40 37 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-i</bold>
###xml 95 96 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 137 138 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 149 150 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 172 173 172 173 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 189 190 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 201 202 201 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 215 216 215 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 689 692 689 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-b</bold>
###xml 694 698 694 698 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c-h </bold>
###xml 720 722 720 722 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c </bold>
###xml 761 764 761 764 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-b</bold>
###xml 772 773 772 773 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 780 783 780 783 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d-h</bold>
###xml 791 792 791 792 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
Detailed pattern of Cre expression. (a-i) Immunohistochemical localization of Cre expression. (a) Basal ganglia, (b) prefrontal cortex, (c) cortex, (d) olfactory nucleus, (e) hippocampus, (f) septum, (g) thalamus, (h) hypothalamus and (i) retina. Abbreviations: Acb: nucleus accumbens; CA2: hippocampus CA2 field; CL: centrolateral thalamic nucleus; CM: central medial thalamic nucleus; CPu: caudate putamen; DG: dentate gyrus; GCL: ganglion cell layer; INL: inner nuclear layer; ipl: inner plexiform layer; LD: laterodorsal thalamic nucleus; ONL: outer nuclear layer; opl: outer plexiform layer. Tu: olfactory tubercle; VI: layer VI of the cortex; VMH: ventromedial hypothalamic nucleus; a-b, c-h are coronal sections; c is a sagittal section. Magnification: (a-b) 25x; (c) 5x; (d-h) 50x; (i) 100x.
###end p 16
###begin p 17
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of D1Cre in neurons expressing D1R mRNA</bold>
###xml 249 250 249 250 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 271 272 271 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 276 277 276 277 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 278 279 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
Expression of D1Cre in neurons expressing D1R mRNA. In situ hybridization with a riboprobe specific for D1R mRNA (blue) followed by immunohistochemistry with Cre specific antibody (brown) showing D1Cre and D1R mRNA coexpression in striatal neurons (a) and in the cortex (b). (a,b) 1000x.
###end p 17
###begin p 18
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a&#8211;c</xref>
###xml 512 516 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4d&#8211;f</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4g&#8211;i</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1039 1040 1039 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1336 1338 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
The dynamics of Cre expression was examined during embryonic development and the postnatal period. D1R mRNA expression in the striatum has been reported at E13 in mice [14], therefore we have analyzed Cre protein at E14.5. At E14.5, Cre could not be detected in striatal anlage nor in any brain region (Fig. 4a-c and data not shown). Cre expressing cells appeared in striatal patches, the so-called striosomes at E16.5 and a only very few weakly expressing cells could be detected in the developing cortex (Fig. 4d-f). At E18.5 the number of Cre expressing cells increased in the striatum as well as in the presumptive layer VI of the cortex (Fig. 4g-i). At postnatal days 0 and 3 (P0 and P3), Cre recombinase was still predominant in the striosomal neurons and layer VI of the cortex (Fig. 5). At P6, Cre expression started to be seen between the patches. Cre expression expanded progressively until the adult stage. Transient and very weak expression was observed in the CA1 region of the hippocampus and in layer IV of the cortex (Fig. 5). These results indicate that Cre starts to be expressed, albeit at low levels, at E16 in the striosomal neurons of the striatum. At the end of the first week after birth, Cre expression is seen also in cell bodies of the matrix, recapitulating the pattern of expression described for D1R mRNA [15-17].
###end p 18
###begin p 19
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cre expression during embryonic development</bold>
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 121 122 121 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 266 269 266 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b-c</bold>
###xml 414 417 414 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e-f</bold>
###xml 557 560 557 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h-i</bold>
###xml 579 580 579 580 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 581 582 581 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 583 584 583 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 592 593 592 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 594 595 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 596 597 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 598 599 598 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 600 601 600 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 602 603 602 603 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
Cre expression during embryonic development. DAPI staining on coronal sections of embryos at E14.5, E16.5 and E18.5 (a,d,g). The regions analyzed in striatum and cortex by immunohistochemistry with Cre antibody are boxed. No Cre positive cells at E14.5 are visible (b-c). At E16.5 Cre expressing cells are detected in the striatum (str) and a few scattered weakly expressing cells are observed in the cortex (cx) (e-f). At E18.5, more Cre positive cells are found in the striatum. Cre expression appeared in the cortical plate, in the presumptive layer VI (h-i). Magnification: (a,d,g) 100x (b,c,e,f,h,i) 200x.
###end p 19
###begin p 20
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cre expression during postnatal development</bold>
###xml 93 96 93 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-c</bold>
###xml 106 109 106 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d-f</bold>
###xml 321 326 321 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a,d,g</bold>
###xml 359 364 359 364 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c,f,i</bold>
###xml 374 377 374 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g-i</bold>
###xml 563 564 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 567 568 567 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 569 570 569 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 571 572 571 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 573 574 573 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 582 583 582 583 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 584 585 584 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 586 587 586 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
Cre expression during postnatal development. Immunohistochemical localization of Cre. At P0 (a-c) and P3 (d-f), striatal Cre is restricted to the patch compartment (arrowheads). Expression in layer VI of the cortex is present already at birth. Transient and very weak expression is visible in the CA1 hippocampal region (a,d,g) and in layer IV of the cortex (c,f,i). At P6 (g-i), striatal Cre expression starts in the matrix compartment (asterisk), between the patches (arrowheads). Expression in CA1 and cortex layer IV disappears progressively. Magnification: (a,b,d,e,g,h) 50x; (c,f,i) 100x.
###end p 20
###begin p 21
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R </italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 275 281 275 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6d</xref>
###xml 513 524 513 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b, c, e, f</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 562 568 562 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 693 698 693 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b, f</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
###xml 290 294 <span type="species:ncbi:10090">mice</span>
In order to assess the specificity and the onset of Cre activity we have crossed D1Cre transgenic mice with the R26R reporter line [18] (Figure 6). We rule out the possibility of recombination in regions outside the CNS as shown at E11 by beta-galactosidase assay in the R26RD1Cre reporter mice (Fig. 6a). Interestingly, we were able to detect Cre activity in the tectum above the mesencephalic region (Fig. 6d). The pattern of recombination induced by Cre recombinase was also analyzed in the adult brains (Fig. 6b, c, e, f). Beta-galactosidase activity in R26RD1Cre was induced not only in the major areas of Cre expression shown in Figure 2, but also layers in IV to VI in the cortex (Fig. 6b, f) and in the CA1 region (Fig. 6c), expressing the Cre recombinase in early postnatal development (Figure 5).
###end p 21
###begin p 22
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 49 55 49 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cre activity in embryonic and adult brain in <italic>R26R</italic><sup>D1Cre </sup>mice</bold>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R </italic>
###xml 357 360 357 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d, </bold>
###xml 483 486 483 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b,e</bold>
###xml 497 500 497 500 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b,f</bold>
###xml 519 520 519 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 614 615 614 615 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 623 624 623 624 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 632 635 632 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b,c</bold>
###xml 643 646 643 646 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e,f</bold>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
Cre activity in embryonic and adult brain in R26RD1Cre mice. (a) Cre activity is analyzed by expression of beta-galactosidase activity (blue staining) at E10.5. The reporter mice are heterozygous for the R26R allele. Positive signal is present in the developing brain at this stage in the tectum above the mesencephalic fold (boxed area), as shown also in (d, arrowhead). In the adult brain, beta-galactosidase activity analyzed in coronal vibratome sections is present in striatum (b,e), cortex (b,f) and hippocampus (c). CA2: hippocampus CA2 field; DG: dentate gyrus; VI: layer VI of the cortex. Magnification: (a) 20x, (d) 40x, (b,c) 50x, (e,f) 100x.
###end p 22
###begin p 23
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a</xref>
###xml 1173 1179 1173 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 1190 1192 1190 1192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b</xref>
We next examined whether Cre expression was confined to a specific subpopulation of striatal neurons. In the striatum, two subtypes of spiny neurons are involved in the so called "direct-" and "indirect-pathway". The direct pathway originates from striatal neurons projecting directly to the medial globus pallidus (GPm) and the substantia nigra pars reticulata (SNr). The neurons contributing to the indirect pathway are instead connected to these areas via the basal ganglia. Although it is still a matter of debate, it has been classically thought that the direct pathway neurons express the D1 dopamine receptor and the indirect-pathway neurons express the D2 receptor (D2R) [19,20]. In order to establish whether Cre expression is confined to a specific subpopulation, we retrogradely labeled neurons from the striatonigral pathway by stereotaxic injection of red fluorescent latex spheres into the substantia nigra pars reticulata and localized Cre within the striatum by immunofluorescence (Fig. 7a). Double labeling of neuron-specific class III beta-tubulin and Cre recombinase showed that the majority of striatal neurons express the Cre recombinase driven by the Drd1a gene (Fig. 7b). This experiment showed that Cre expression was not restricted to the retrogradely labeled neurons which correspond to neurons of the direct pathway that project directly to the substantia nigra.
###end p 23
###begin p 24
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cre expression in striatal neurons</bold>
###xml 37 38 37 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 186 187 186 187 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 333 334 333 334 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 534 535 534 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 751 757 749 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-b-c </bold>
###xml 780 784 778 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a,b </bold>
###xml 791 792 789 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
Cre expression in striatal neurons. (a) Retrograde labeling of striatonigral neurons within the striatum (red fluorescence). Cre was labeled by immunofluorescence (green fluorescence). (b) Double immunofluorescence against Cre (green fluorescence) and neuron-specific class III tubulin (TujI monoclonal antibody, red fluorescence). (c) Expression of Cre protein in neurons expressing D2R mRNA by in situ hybridization with a riboprobe specific for D2R mRNA (blue) followed by immunohistochemistry with Cre specific antibody (brown). (d) Quantification of Cre positive neurons expressing D2R mRNA. Neurons expressing either Cre protein or D2R mRNA were also counted. Reported is the % of neurons per each group. The data are expressed as mean +/- SEM. a-b-c are coronal sections; (a,b 400x; (b) 1000x.
###end p 24
###begin p 25
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7c</xref>
###xml 484 486 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7d</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1155 1157 1155 1157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
To further assess the subpopulation specificity of the D1Cre transgene, we checked whether also D2R-positive cells express Cre protein in the striatum. Therefore, we performed in situ hybridization by using a D2R-specific riboprobe followed by immunohistochemistry with Cre-specific antibody (Fig. 7c). This experiment shows that D1Cre is expressed also in about 40% of D2R-expressing cells, and that only about 20% of D2R positive cells do not express Cre at detectable levels (Fig. 7d) while about 40% of the neurons express D1Cre but not D2R mRNA. Therefore, we conclude that at least 80% of the striatal neurons express D1Cre. It has to be mentioned that some studies indicate that there is only very little overlap in the number of neurons expressing both receptors [19,21]. According to these studies we were not expecting expression of D1Cre in D2R positive cells to such an extent. However, depending on the sensitivity and resolution of the adopted technical approach, others studies reveal that there is a higher degree of overlap [22] and that possibly all dopamine receptor-containing neurons, in the striatum, express both receptor types [23,24]. Our study does not solve this debate about the degree of overlap between D1R and D2R, however, the finding that Cre expression is detectable in both neuronal subpopulations, D1R- and/or D2R-expressing neurons, suggests that these receptors are at least partially coexpressed in a certain proportion of striatal neurons (about 40%).
###end p 25
###begin p 26
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7d</xref>
###xml 343 348 343 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Creb1</italic>
###xml 348 353 348 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 359 365 359 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CaMKIV</italic>
###xml 365 370 365 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GR</italic>
###xml 378 383 378 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
The expression of D1Cre not only in D1R positive neurons (Fig. 3a), but also in D2R positive cells (Fig. 7d), makes the D1Cre line suitable for gene inactivation in virtually all dopaminoceptive neurons of the striatum. The pattern of recombination induced by Cre recombinase was verified by crossing D1Cre transgenic animals to 3 loxP lines, Creb1loxP [25], CaMKIVloxP [26], GRloxP [18,27]. Recombination was visualized by loss of CREB, CaMKIV and GR proteins in the respective mutants. Loss of CREB, CaMKIV and GR proteins was extensive (at least 90%) in the main regions of Cre expression, striatum, nucleus accumbens, olfactory tubercles, and layer VI of the cortex (Figure 8). In the hippocampus, expression of Cre in the CA2 subfield results in loss of CREB, and CaMKIV in the corresponding cells. No or very marginal loss of CREB, CaMKIV and GR was observed in CA1 and layer IV of the cortex, in spite of the transient expression of Cre during the early postnatal period. These results underscore the importance of verifying recombination in the context of the loxP modified allele of interest.
###end p 26
###begin p 27
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Creb1</italic>
###xml 39 44 39 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre</sup>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CaMKIV</italic>
###xml 52 58 52 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 62 64 62 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GR</italic>
###xml 64 70 64 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pattern of recombination in adult <italic>Creb1</italic><sup>D1Cre</sup>, <italic>CaMKIV</italic><sup>D1Cre </sup>and <italic>GR</italic><sup>D1Cre </sup>mice</bold>
###xml 112 115 112 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a-f</bold>
###xml 131 134 131 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g-l</bold>
###xml 148 151 148 151 <bold xmlns:xlink="http://www.w3.org/1999/xlink">m-r</bold>
###xml 206 217 206 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a,b,g,h,m,n</bold>
###xml 228 239 228 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c,d,i,j,o,p</bold>
###xml 258 269 258 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e,f,k,l,q,r</bold>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Creb1</italic>
###xml 385 389 385 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP</sup>
###xml 391 397 391 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CaMKIV</italic>
###xml 397 402 397 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 406 408 406 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GR</italic>
###xml 408 413 408 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">loxP </sup>
###xml 635 636 635 636 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 637 638 637 638 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 647 648 647 648 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 649 650 649 650 <bold xmlns:xlink="http://www.w3.org/1999/xlink">l</bold>
###xml 658 659 658 659 <bold xmlns:xlink="http://www.w3.org/1999/xlink">m</bold>
###xml 660 661 660 661 <bold xmlns:xlink="http://www.w3.org/1999/xlink">r</bold>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
Pattern of recombination in adult Creb1D1Cre, CaMKIVD1Cre and GRD1Cre mice. Recombination is shown in striatum (a-f), hippocampus (g-l) and cortex (m-r). Recombination is followed by disappearance of CREB (a,b,g,h,m,n), CaMKIV (c,d,i,j,o,p) and GR proteins (e,f,k,l,q,r) in the respective mutants. All animals are homozygous for the respective loxP-modified allele in the case of Creb1loxP, CaMKIVloxP and GRloxP mice. Control animals are devoid of the D1Cre transgene while mutant animals carry the D1Cre trangene, as indicated. The hippocampus CA2 field is indicated by arrowheads. The cortical layers are indicated. Magnification: (a-f) 200x; (g-l) 50x; (m-r) 54x.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 650 658 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 799 805 799 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 996 1001 996 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a, b</xref>
The pattern of expression obtained with the D1Cre YAC transgene was very reproducible between transgenic lines. The expression level was essentially only dependent on the copy number of the transgene. These observations illustrate well the properties of transgenes based on large DNA segments: position-independent and copy-number dependent expression of the transgene. This correlation between expression pattern and copy number usually does not apply to plasmid-based constructs [28]. The pattern of Cre expression as seen in the D1Cre transgenic animals is very close to the pattern of expression of the endogenous Drd1a gene reported in previous in situ hybridization studies [29]. Moreover, the developmental and postnatal patterns of expression match the patterns described for the endogenous Drd1a gene [15-17]. We have also performed in situ hybridization with D1R riboprobe in combination with Cre immunohistochemistry in adult cortex and striatum and found high levels of overlap (Fig. 3a, b).
###end p 29
###begin p 30
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 129 132 <span type="species:ncbi:10116">rat</span>
Several publications have suggested that D1 and D2 receptors are segregated specifically on distinct neuronal populations of the rat striatum that projects directly to substantia nigra pars reticulata and to globus pallidus respectively [20,30]. Some other publications have however demonstrated that D1 and D2 might actually be coexpressed [22-24]. These discordant studies clearly indicate that a fine modulation of expression levels of D1R and D2R takes place in the dopaminoceptive neurons. In our transgenic line, we observe that Cre is expressed in a majority of striatal neurons, but it remains open whether our vector, even though it contains large segments of 5'- and 3'- flanking sequences, carries all necessary elements required to achieve this fine modulation of expression levels within striatum.
###end p 30
###begin p 31
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 133 148 <span type="species:ncbi:10090">transgenic mice</span>
A potential application of D1Cre transgene for isolation of mutated dopaminoceptive cells is represented by the generation of double transgenic mice with BAC-D1GFP and BAC-D2GFP obtained by the GENSAT BAC Transgenic project [31]. The D1Cre expression pattern matches quite closely the BAC-D1GFP pattern in the medium spiny neurons of the striatum, therefore one would expect to isolate recombined GFP positive cells. However deeper analysis by costaining is required to compare the two transgenic lines.
###end p 31
###begin p 32
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R26R</italic>
###xml 350 356 350 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre </sup>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
When recombination was verified in the context of three loxP-modified alleles, loss of the respective proteins were largely confined to the main areas of Cre expression. Thus loss of CREB, CaMKIV and GR were extensive in striatum, layer VI of the cortex and CA2 of the hippocampus (Figure 8). However, induction of beta-galactosidase activity in R26RD1Cre reporter mice showed a more widespread pattern of recombination in layer IV of the cortex and in the CA1 of the hippocampus (Figure 6). One possible explanation for this could be that scattered recombination, as caused by weak and transient Cre expression occurring at early postnatal stages (Figure 5), is easily underestimated when followed by loss of the respective protein but very visible when revealed by beta-galactosidase staining. This may be also related to a tissue-specific difference in the stability of CREB, CaMKIV and GR proteins in CA1 and layer IV.
###end p 32
###begin p 33
In view of the patterns of recombination restricted to the major dopaminoceptive regions as seen in the context of the CREB, CaMKIV and GR mutations, the D1Cre line should be useful to evaluate the contribution of these, and others, signaling molecules to the dopaminergic system. The D1Cre line, combined with specific pharmacological treatment may provide a powerful tool do genetically dissect signalling pathways underlying dopaminergic neurotransmission.
###end p 33
###begin title 34
Conclusion
###end title 34
###begin p 35
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
We present the generation and characterization of a transgenic mouse line expressing the Cre recombinase under the control of the D1R regulatory elements. We show that this transgenic line can be used successfully for the conditional ablation of specific genes important for biological processes involving dopamine signaling.
###end p 35
###begin title 36
Methods
###end title 36
###begin title 37
D1Cre YAC construction
###end title 37
###begin p 38
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hind</italic>
###xml 507 510 507 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 768 771 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 811 814 811 814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 872 878 872 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 937 939 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 217 222 <span type="species:ncbi:4932">yeast</span>
The small insert Princeton mouse YAC library [12] was screened by PCR (primers: 5'-TTT CAT CCT CCC TCA TAA GC-3' and 5'-TTCGACAGGGTTTCCATTAC-3'). To allow for subsequent modification, the YAC was transferred into the yeast strain YPH925 [33]. To insert the Cre recombinase into the Drd1a gene, a targeting vector was constructed by cloning a 800 bp 5' homology region (primers:5'-GGG GCG GCC GCG GTC CTG CCC TAA GAA CGA G-3'and 5'-ACC AAG CTT AGC CAG ACT TCC CCC-3'), the nlsCre open reading frame (HindIII-EcoRI fragment from pHD2 nlsCre, [13]) and a 500 bp 3' homology region (primers: 5'-TTT GGG TGG GCG AAT TCT TCC CTG AAC CCC ATT ATT TAT-3' and 5'-GAT AAT ACT CCC AAA CTG GAT TTC AGA GCC GAA GTC ATT T-3') bearing a unique XbaI restirction site into the NotI and BamHI sites of the pRS306 vector [34]. The XbaI linearized targeting vector was then used to modify the Drd1a containing YAC by classical "pop-in pop-out" modification [35].
###end p 38
###begin title 39
Generation of transgenic animals
###end title 39
###begin p 40
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drd1a </italic>
###xml 660 675 <span type="species:ncbi:10090">transgenic mice</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
The YAC DNA from one of the positive colonies was purified as described [36] and microinjected into the pronucleus of FVB/N oocytes. Founders were identified by Southern blot analysis of BamHI digested genomic DNA using the 5' homology region as a probe. Since this probe hybridizes identically to the endogenous Drd1a gene and to the modified YAC, it was used to determine the copy number of the transgene in the various founders. For subsequent routine genotyping, dot blot analysis was performed with a probe for the Cre open reading frame. The transgenic line was maintained by backcrossing to C57Bl/6. To generate the respective mutant animals, the D1Cre transgenic mice were first crossed to mice homozygous for the respective loxP-modified allele. Offspring hemizygous for the transgene and heterozygous for the loxP-modified allele were in turn crossed to mice homozygous for the loxP-modified allele to generate mutant animals with an expected frequency of 25%. We did not observe cases of germline recombination with this transgenic line.
###end p 40
###begin title 41
Histology
###end title 41
###begin p 42
###xml 325 327 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1103 1104 1095 1096 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 278 284 <span type="species:ncbi:9986">rabbit</span>
###xml 333 339 <span type="species:ncbi:9986">rabbit</span>
###xml 382 386 <span type="species:ncbi:9925">goat</span>
###xml 439 442 <span type="species:ncbi:9685">cat</span>
###xml 456 462 <span type="species:ncbi:9986">rabbit</span>
###xml 507 510 <span type="species:ncbi:9685">cat</span>
###xml 524 529 <span type="species:ncbi:10090">mouse</span>
###xml 607 610 <span type="species:ncbi:9685">cat</span>
###xml 776 782 <span type="species:ncbi:9986">rabbit</span>
###xml 821 826 <span type="species:ncbi:10090">mouse</span>
Paraffin sections (7 mum) from mouse embryos at different developmental stages and vibratome sections (50 mum) prepared from brains of perfused mice (0.1 M phosphate-buffered 4% paraformaldehyde) were used for immunohistochemical labeling. The following antibodies were used: a rabbit polyclonal anti-Cre antibody (1:3,000, [37]), a rabbit polyclonal anti-CREB antibody (1:3000), a goat polyclonal anti-CaMKIV antibody (1:200, Santa Cruz, cat. Sc-1546), a rabbit polyclonal GR antibody (1:2000, Santa Cruz, cat. Sc-1004), a mouse monoclonal anti class III beta-tubulin antibody (1:400, clone TujI, Covance, cat. MMS-435P). Immunohistochemistry was performed using the avidin-biotin system (Vectastain, Vector Labs). Immunofluorescence was achieved using Alexa488 coupled anti-rabbit antibody and an Alexa594-coupled anti-mouse antibody (Molecular Probes) as secondary antibodies. Beta-galactosidase activity was revealed by incubating embryos or vibratome sections at 37degreesC overnight in X-Gal staining solution (5 mM potassium hexacyanoferrate (III), 5 mM potassium hexacyanoferrate (II), 2 mM MgCl2, 0.01% NP-40, 0.02% sodium deoxycholate, 1 mg/ml X-gal, 20 mM Tris/HCl, pH7.5).
###end p 42
###begin p 43
###xml 367 372 <span type="species:ncbi:9823">swine</span>
Non-radioactive in situ hybridization was performed on vibratome sections (20 mum) prehybridized, after a step with Proteinase K, at 70degreesC for 1 hour. Hybridization with specific riboprobe occurs overnight at 70degreesC in the hybridization solution. After two washing steps the sections were incubated with the anti-digoxygenin antibody (1:10000) in 20% normal swine serum. The development of the reaction was done with NBT/BCIP (Roche). After washing in PBS and PBST, the sections were processed for immunohistochemistry as described above.
###end p 43
###begin title 44
Cell counting
###end title 44
###begin p 45
To estimate the % of neurons expressing D2R and Cre, cells positive for both signals were counted in nine nonoverlapping microscopic field at 400x magnification. Neurons expressing either Cre protein or D2R mRNA were also counted. The data are expressed as mean +/- SEM.
###end p 45
###begin title 46
Retrograde tracing of striatonigral neurons
###end title 46
###begin p 47
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 237 240 <span type="species:ncbi:9685">cat</span>
Mice were injected stereotaxically into the right and left substantia nigra pars reticulata (AP = -3.28 mm, DV = -4.15 mm, L = -1.3 mm and +1.3 mm) with 2 mul of a carboxylate-modified red latex FluoroSpheres solution (Molecular Probes, cat. L-2783,). Three days later, the animals were perfused through the ascending aorta with 0.1 M phosphate-buffered 4% paraformaldehyde and the brains were removed to be postfixed for 4 hr at 4degreesC. Cre immunofluorescence was performed on cryostat-cut free-floating 30 mum-thick sections. Sections were examined on a confocal microscope (MRC 1024, Bio-Rad Laboratories, Hemel Hempstead, Hertfordshire, U.K.) fitted on an inverted microscope (Axiovert 100, Zeiss, Oberkochen, Germany).
###end p 47
###begin title 48
List of abbreviations
###end title 48
###begin p 49
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 5 10 <span type="species:ncbi:4932">yeast</span>
YAC: yeast artificial chromosome; CREB: cAMP-responsive element binding protein; CaMKIV: Ca2+/Calmodulin-dependent protein kinase IV; GR: glucocorticoid receptor; D1R: dopamine D1 receptor; D2R: dopamine D2 receptor
###end p 49
###begin title 50
Authors' contributions
###end title 50
###begin p 51
###xml 469 474 469 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">D1Cre</sup>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
TL conceived the study, generated the D1Cre transgenic line and most of the conditional mutants used for recombination analysis, drafted the manuscript. RP carried out part of the histological characterization of the line, participated in the coordination of the study and helped to draft the manuscript. DD performed the retrograde labeling experiment. MW performed the in situ hybridization experiments. EC generated the CamKIV floxed mice. MT and FT generated the GRD1Cremutants used for the recombination analysis. SNS conceived and participated in the retrograde labeling experiments. GS participated in the design and coordination of the study and in the draft of the manuscript. All authors read and approved the final manuscript.
###end p 51
###begin title 52
Acknowledgements
###end title 52
###begin p 53
We thank Heidrun Kern, Heike Glaser, and Katrin Anlag for expert technical assitance. We thank Dr. Brenda Stride and Dr. Jan Rodriguez for critically reading the manuscript. This work was supported by the DFG (Germany), by the "Fonds der Chemischen Industrie", the European Community, the BMBF (Germany) and by the Alexander von Humboldt-Stiftung to GS, by HFSPO and SNF (Switzerland) to TL and by FMRE (Belgium), FNRS (Belgium) and "Action de Recherche Concerte" to SNS.
###end p 53
###begin article-title 54
Mnemonic functions of the basal ganglia
###end article-title 54
###begin article-title 55
Getting formal with dopamine and reward
###end article-title 55
###begin article-title 56
Dopamine dysregulation syndrome in Parkinson's disease
###end article-title 56
###begin article-title 57
Dopamine: a key regulator to adapt action, emotion, motivation and cognition
###end article-title 57
###begin article-title 58
It could be habit forming: drugs of abuse and striatal synaptic plasticity
###end article-title 58
###begin article-title 59
Structure and function of dopamine receptors
###end article-title 59
###begin article-title 60
Dopamine receptors: from structure to function
###end article-title 60
###begin article-title 61
Using conditional mutagenesis to study the brain
###end article-title 61
###begin article-title 62
Requirement for hippocampal CA3 NMDA receptors in associative memory recall
###end article-title 62
###begin article-title 63
The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory
###end article-title 63
###begin article-title 64
###xml 25 30 <span type="species:ncbi:4932">yeast</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Genomic analysis using a yeast artificial chromosome library with mouse DNA inserts
###end article-title 64
###begin article-title 65
Regulation of Cre recombinase activity by the synthetic steroid RU 486
###end article-title 65
###begin article-title 66
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Dopamine control of striatal gene expression during development: relevance to knockout mice for the dopamine transporter
###end article-title 66
###begin article-title 67
###xml 116 119 <span type="species:ncbi:10116">rat</span>
Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution
###end article-title 67
###begin article-title 68
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Ontogeny of the D1 dopamine receptor in the rat striatonigral system: an immunohistochemical study
###end article-title 68
###begin article-title 69
Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors
###end article-title 69
###begin article-title 70
Generalized lacZ expression with the ROSA26 Cre reporter strain
###end article-title 70
###begin article-title 71
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
###end article-title 71
###begin article-title 72
###xml 51 54 <span type="species:ncbi:10116">rat</span>
D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum
###end article-title 72
###begin article-title 73
Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens
###end article-title 73
###begin article-title 74
Coordinated expression of dopamine receptors in neostriatal medium spiny neurons
###end article-title 74
###begin article-title 75
###xml 41 44 <span type="species:ncbi:10116">rat</span>
Dopamine receptor subtypes colocalize in rat striatonigral neurons
###end article-title 75
###begin article-title 76
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
###end article-title 76
###begin article-title 77
Disruption of CREB function in brain leads to neurodegeneration
###end article-title 77
###begin article-title 78
Conditional mutagenesis of CamKIV
###end article-title 78
###begin article-title 79
Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
###end article-title 79
###begin article-title 80
Repeat-induced gene silencing in mammals
###end article-title 80
###begin article-title 81
Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission
###end article-title 81
###begin article-title 82
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies
###end article-title 82
###begin article-title 83
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast kar1 mutants provide an effective method for YAC transfer to new hosts
###end article-title 84
###begin article-title 85
###xml 32 37 <span type="species:ncbi:4932">yeast</span>
###xml 97 121 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae
###end article-title 85
###begin article-title 86
Targeting mutations to YACs by homologous recombination
###end article-title 86
###begin article-title 87
Preparation, Manipulation, and Mapping of HMW DNA
###end article-title 87
###begin article-title 88
Inducible site-specific recombination in the brain
###end article-title 88

